Student Name: Yeosmize Student No.: 1023018
Pharmacotherapy Workup © Notes Care Plan
Patient Initials: LI Date: Aug 15, 2016
Medical condition
Rosacea
Patient History: LI is a 50 year-old woman who presented to the pharmacy to pick up her prescription for minocycline 100 mg, take 1 tablet once daily for 60 days. She is diagnosed with moderate rosacea. LI has redness on her cheeks and nose, and also few papules. LI has been using topical metronidazole cream before for a few months but it doesn’t work for her. LI does not have any drug allergies. Her other medical condition is depression. Her current medications include trazodone 100mg (1 tablet twice …show more content…
It affects mostly in women, age between 30-50 years old. It is also known as “adult acne”. The pathogenesis of rosacea is not well understood, however there are several pathways that lead to the development of rosacea: (1) abnormalities in innate immunity, is the overproduction of peptide cathalicidin and the stratum corneum tryptic enzyme that leads to the production of immune system peptide and triggers symptoms of rosacea. (2) microorganisms: Demodex folliculoriium . (3) UV damage and (4) vascular hyperreactivity. There are 4 subtypes of rosacea: (1) erythematotelangietactic, characterized by facial erythema and precurrent episodes of flushing. (2) papulopustular, presence of papules and pustules without comedone on the face. (3) phymatous, tissue hypertrophy especially on the nose. (4) ocular rosacea, include blepharitis, conjunctival hyperemia, chalazion. Symptoms of ocular rosacea include dryness, stinging, burning, pruritus, photosensitivity and blurred vision. Almost 50% of patients with rosacea will experience ocular symptoms. External triggers for rosacea are: sunlight, heat, how beverages, spicy foods, vinegar, alcohol, medications (applying topical steroid on the face, ACEI, niacin), astringents, and stress. Rosacea does not improve on its own, and it will worsen if it is left …show more content…
e-CPS [Internet]. Ottawa(ON): Canadian Pharmacists Association;c2016 [November 2014; cited 2016 Aug 15]. Zopiclone[product monograph]. Available from: www.e-therapeutics.ca
7. e-CPS [Internet]. Ottawa(ON): Canadian Pharmacists Association;c2016 [2015 Sep 18; cited 2016 Aug 15]. Mirtazapine [product monograph]. Available from: www.e-therapeutics.ca
8. Maier LE. Management of rosacea.[Internet]. 2016. [updated 2016 June 14; cited 2016 Aug 15]. Available from: http://www.uptodate.com/contents/management-of-rosacea?source=search_result&search=rosacea&selectedTitle=1~38
9. Dahl MV. Rosacea: pathogenesis, clinical features, and diagnosis.[Internet]. 2016. [updated 2016 Feb 4, cited 2016 Aug 15]. Available from: http://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis?source=search_result&search=rosacea&selectedTitle=2~38
10. Rosacea. Canadian Dermatology Association. Available from: http://www.dermatology.ca/skin-hair-nails/skin/rosacea/
11. Webster GF. An open-label, community-based, 12-week assessment of the effectiveness and safety of monotherapy with doxycycline 40 mg (30-mg immediate-release and 10-mg delayed-release beads). Cutis 2010;
Pharmacotherapy Workup © Notes Care Plan
Patient Initials: LI Date: Aug 15, 2016
Medical condition
Rosacea
Patient History: LI is a 50 year-old woman who presented to the pharmacy to pick up her prescription for minocycline 100 mg, take 1 tablet once daily for 60 days. She is diagnosed with moderate rosacea. LI has redness on her cheeks and nose, and also few papules. LI has been using topical metronidazole cream before for a few months but it doesn’t work for her. LI does not have any drug allergies. Her other medical condition is depression. Her current medications include trazodone 100mg (1 tablet twice …show more content…
It affects mostly in women, age between 30-50 years old. It is also known as “adult acne”. The pathogenesis of rosacea is not well understood, however there are several pathways that lead to the development of rosacea: (1) abnormalities in innate immunity, is the overproduction of peptide cathalicidin and the stratum corneum tryptic enzyme that leads to the production of immune system peptide and triggers symptoms of rosacea. (2) microorganisms: Demodex folliculoriium . (3) UV damage and (4) vascular hyperreactivity. There are 4 subtypes of rosacea: (1) erythematotelangietactic, characterized by facial erythema and precurrent episodes of flushing. (2) papulopustular, presence of papules and pustules without comedone on the face. (3) phymatous, tissue hypertrophy especially on the nose. (4) ocular rosacea, include blepharitis, conjunctival hyperemia, chalazion. Symptoms of ocular rosacea include dryness, stinging, burning, pruritus, photosensitivity and blurred vision. Almost 50% of patients with rosacea will experience ocular symptoms. External triggers for rosacea are: sunlight, heat, how beverages, spicy foods, vinegar, alcohol, medications (applying topical steroid on the face, ACEI, niacin), astringents, and stress. Rosacea does not improve on its own, and it will worsen if it is left …show more content…
e-CPS [Internet]. Ottawa(ON): Canadian Pharmacists Association;c2016 [November 2014; cited 2016 Aug 15]. Zopiclone[product monograph]. Available from: www.e-therapeutics.ca
7. e-CPS [Internet]. Ottawa(ON): Canadian Pharmacists Association;c2016 [2015 Sep 18; cited 2016 Aug 15]. Mirtazapine [product monograph]. Available from: www.e-therapeutics.ca
8. Maier LE. Management of rosacea.[Internet]. 2016. [updated 2016 June 14; cited 2016 Aug 15]. Available from: http://www.uptodate.com/contents/management-of-rosacea?source=search_result&search=rosacea&selectedTitle=1~38
9. Dahl MV. Rosacea: pathogenesis, clinical features, and diagnosis.[Internet]. 2016. [updated 2016 Feb 4, cited 2016 Aug 15]. Available from: http://www.uptodate.com/contents/rosacea-pathogenesis-clinical-features-and-diagnosis?source=search_result&search=rosacea&selectedTitle=2~38
10. Rosacea. Canadian Dermatology Association. Available from: http://www.dermatology.ca/skin-hair-nails/skin/rosacea/
11. Webster GF. An open-label, community-based, 12-week assessment of the effectiveness and safety of monotherapy with doxycycline 40 mg (30-mg immediate-release and 10-mg delayed-release beads). Cutis 2010;